Single doses of 450mg, 300mg, and 150mg of CD388 conferred 76%, 61%, and 58% protection, respectively, from symptomatic influenza over 24 weeks compared to placebo, the company said.
While many analysts on Wall Street have raised their price targets on GMS after The Wall Street Journal’s report that Home Depot may have submitted a competing bid against QXO, RBC Capital said the lack of details “raises questions.”
Analysts noted Hinge Health’s strong return on investment, rapid automation of care delivery, and profitability milestones as key drivers of their bullish stance.
RBC Bearings (NYSE:RBC) meets quality investing criteria with strong ROIC, EBIT growth, and profit quality, though its valuation remains high. A deeper look for long-term investors.
Investors are growing cautious about the timeline and payoff of Adobe’s AI initiatives, despite the company beating Q2 estimates and raising its full-year revenue forecast.
The Paris Air Show, which begins Monday, is the aviation industry’s largest trade show and typically sees several deals between aircraft manufacturers and airlines.
Starbucks Corporation (NASDAQ:SBUX) shares are moving higher on Wednesday. Analysts at RBC Capital and TD Securities weighed in on the stock. Here's what you need to know.
The clinical hold is due to the identification of a safety signal, characterized by decreases in CD4+ T-cell (CD4) and absolute lymphocyte counts, in certain participants receiving the combination of the two agents.
Wall Street’s bearish price targets for the stocks in this article signal serious concerns.
Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.
Bearings manufacturer RBC Bearings (NYSE:RBC) fell short of the market’s revenue expectations in Q1 CY2025, but sales rose 5.8% year on year to $437.7 million. Its non-GAAP EPS of $2.83 per share was 4.7% above analysts’ consensus estimates.
